Association of BRAF V600E with Hypothalamic-Pituitary-Adrenal Axis Involvement in Erdheim-Chester Disease
Open Access
- 1 July 2020
- journal article
- research article
- Published by Elsevier in Endocrine and Metabolic Science
- Vol. 1 (1-2) , 100051
Abstract
No abstract availableKeywords
Funding Information
- National Human Genome Research Institute
- Clinical Center
This publication has 17 references indexed in Scilit:
- Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular eraBlood, 2020
- Neurological manifestations of Erdheim–Chester DiseaseAnnals of Clinical and Translational Neurology, 2020
- The clinical spectrum of Erdheim-Chester disease: an observational cohort studyBlood Advances, 2017
- Cortisol in the Evaluation of Adrenal InsufficiencyJAMA, 2016
- Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineagesBlood, 2016
- Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2016
- Endocrine Manifestations in a Monocentric Cohort of 64 Patients With Erdheim-Chester DiseaseThe Journal of Clinical Endocrinology & Metabolism, 2016
- Erdheim–Chester disease: A systematic reviewCritical Reviews in Oncology/Hematology, 2015
- Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester diseaseBlood, 2014
- Bilateral Adrenal Infiltration in Erdheim-Chester Disease. Report of Seven Cases and Literature ReviewThe Journal of Clinical Endocrinology & Metabolism, 2007